• Head office

  3-11-8 Sendagaya, Shibuya-ku, Tokyo 151-0051 Japan

• Aoyama Office

  2-12-8, Kita-Aoyama, Minato-ku, Tokyo 107-0061 Japan

• President

  Shinichi Torii, Ph.D. CEO

• Nov. 2019

  Company establishment

• Jan. 2020

  Founder round

• Mar. 2020

  Capital increased from MUCAP.

• Apr. 2020

  Head office moved to Sendagaya, Shibuya-ku

• Jul. 2020

  Nihonbashi Lab established and started

• Shinichi Torii, Ph.D.

  CEO & President

Scientific Advisory Board

• Motomu Kanai, Ph.D.

  Professor,
  The University of Tokyo Graduate School of Pharmaceutical Sciences
  Laboratory of Synthetic Organic Chemistry

• Taisuke Tomita, Ph.D.

  Professor,
  ​The University of Tokyo Graduate School of Pharmaceutical Sciences
  Laboratory of Neuropathology and Neuroscience

• Prof. Youhei Sohma, Ph.D.

  ​ School of Pharmaceutical Sciences,
  Wakayama Medical University, Department of Medicinal Chemistry

• Yukiko Hori, Ph.D.

  Lecturer
  ​The University of Tokyo Graduate School of Pharmaceutical Sciences
  Laboratory of Neuropathology and Neuroscience